Citation: M. Janic et A. Reggiani, Integrated transport systems in the European Union: an overview of some recent developments, TRANSP REV, 21(4), 2001, pp. 469-497
Authors:
Reggiani, A
Pietra, C
Arban, R
Marzola, P
Guerrini, U
Ziviani, L
Boicelli, A
Sbarbati, A
Osculati, F
Citation: A. Reggiani et al., The neuroprotective activity of the glycine receptor antagonist GV150526: an in vivo study by magnetic resonance imaging, EUR J PHARM, 419(2-3), 2001, pp. 147-153
Authors:
Crespi, F
Corsi, M
Reggiani, A
Ratti, E
Gaviraghi, G
Citation: F. Crespi et al., Involvement of cholecystokinin within craving for cocaine: role of cholecystokinin receptor ligands, EXPERT OP I, 9(10), 2000, pp. 2249-2258
Citation: P. Nijkamp et A. Reggiani, Drivers of innovation: A comparative study on innovation in European cities by means of multi-criteria analysis, TIJD EC SOC, 91(3), 2000, pp. 308-315
Authors:
Ursini, A
Capelli, AM
Carr, RAE
Cassara, P
Corsi, M
Curcuruto, O
Curotto, G
Dal Cin, M
Davalli, S
Donati, D
Feriani, A
Finch, H
Finizia, G
Gaviraghi, G
Marien, M
Pentassuglia, G
Polinelli, S
Ratti, E
Reggiani, A
Tarzia, G
Tedesco, G
Tranquillini, ME
Trist, DG
Van Amsterdam, FTM
Citation: A. Ursini et al., Synthesis and SAR of new 5-phenyl-3-ureido-1,5-benzodiazepines as cholecystokinin-B receptor antagonists (vol 43, pg 3596, 2000), J MED CHEM, 43(26), 2000, pp. 5057-5057
Authors:
Ursini, A
Capelli, AM
Carr, RAE
Cassara, P
Corsi, M
Curcuruto, O
Curotto, G
Dal Cin, M
Davalli, S
Donati, D
Feriani, A
Finch, H
Finizia, G
Gaviraghi, G
Marien, M
Pentassuglia, G
Polinelli, S
Ratti, E
Reggiani, A
Tarzia, G
Tedesco, G
Tranquillini, ME
Trist, DG
Van Amsterdam, FTM
Citation: A. Ursini et al., Synthesis and SAR of new 5-phenyl-3-ureido-1,5-benzodiazepines as cholecystokinin-B receptor antagonists, J MED CHEM, 43(20), 2000, pp. 3596-3613
Authors:
Micheli, F
Di Fabio, R
Capelli, AM
Cugola, A
Curcuruto, O
Feriani, A
Gastaldi, P
Gaviraghi, G
Marchioro, C
Orlandi, A
Pozzan, A
Quaglia, AM
Reggiani, A
van Amsterdam, F
Citation: F. Micheli et al., Cycloalkyl indole-2-carboxylates as useful tools for mapping the "North-Eastern" region of the glycine binding site associated with the NMDA receptor, ARCH PHARM, 332(3), 1999, pp. 73-80
Citation: M. Janic et al., Sustainability of the European freight transport system: Evaluation of innovative bundling networks, TRANSP PL T, 23(2), 1999, pp. 129-156
Authors:
Quartaroli, M
Carignani, C
Dal Forno, G
Mugnaini, M
Ugolini, A
Arban, R
Bettelini, L
Maraia, G
Belardetti, F
Reggiani, A
Trist, DG
Ratti, E
Di Fabio, R
Corsi, M
Citation: M. Quartaroli et al., Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771A, J PHARM EXP, 290(1), 1999, pp. 158-169
Authors:
Ferraro, L
Beani, L
Trist, D
Reggiani, A
Bianchi, C
Citation: L. Ferraro et al., Effects of cholecystokinin peptides and GV 150013, a selective cholecystokinin(B) receptor antagonist, on electrically evoked endogenous GABA releasefrom rat cortical slices, J NEUROCHEM, 73(5), 1999, pp. 1973-1981
Authors:
Di Fabio, R
Conti, N
De Magistris, E
Feriani, A
Provera, S
Sabbatini, FM
Reggiani, A
Rovatti, L
Barnaby, RJ
Citation: R. Di Fabio et al., Substituted analogues of GV150526 as potent glycine binding site antagonists in animal models of cerebral ischemia, J MED CHEM, 42(18), 1999, pp. 3486-3493
Citation: F. Bordi et al., The neuroprotective glycine receptor antagonist GV150526 does not produce neuronal vacuolization or cognitive deficits in rats, EUR J PHARM, 378(2), 1999, pp. 153-160